UNSPSC 85582402: Supplement uvula with synthetic substitute, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement uvula with synthetic substitute, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CUNXJZ

UNSPSC 85582402 Supplement uvula with synthetic substitute, external approach is a Commodity code that shows no alignment with actual state and local procurement activity in the recent opportunities block. The code nominally describes a specific surgical procedure — synthetic uvula augmentation performed externally — but the five most recent state and local solicitations tagged under this code concern inmate medical and pharmacy services, pharmacy benefit management, virtual primary and urgent care, peer support for behavioral health workers, and fire department medical direction. None of these opportunities involve uvula supplementation or any related otolaryngologic procedure. The mismatch suggests either a cataloging error in the source data or that this code is being applied to healthcare procurement categories that fall outside its narrow clinical scope.

Because the recent opportunities show no relevant activity under the code's stated definition, no meaningful assessment of issuing-body mix, geographic spread, or representative procurement patterns can be drawn. State and local governments do solicit comprehensive healthcare services — prison medical contracting, pharmacy benefit administration, virtual care networks, mental health support, and fire department medical oversight — but these fall under broader healthcare and professional-services codes, not a Commodity-tier code for a specific surgical procedure. Practitioners evaluating this code should verify the UNSPSC classification with their procurement contacts before pursuing opportunities, as the current tagging appears to reflect a systematic classification problem rather than genuine activity in the uvula-supplementation market.